<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR54003</article-id>
      <title-group>
        <article-title>Oxyntomodulin, Obestatin and Leptin Potential Weight Reducing Agents: a Review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bairagi</surname>
            <given-names>Shriram</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sadiq</surname>
            <given-names>M.A. Hameed</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patel</surname>
            <given-names>Mohammed Shoaib</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ushir</surname>
            <given-names>Rahul B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patil</surname>
            <given-names>Suraj V.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choudhary</surname>
            <given-names>Ramesh</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Ideal College of Pharmacy and research, Kalyan (E), 421306, Maharashtra, India.</aff>
      <pub-date pub-type="epub" iso-8601-date="2015-08-01">
        <month>08</month>
        <day>01</day>
        <year>2015</year>
      </pub-date>
      <volume>5</volume>
      <issue>4</issue>
      <abstract>
        <p>As obesity remains the center of concern from many decades but yet there is no exact treatment, mostly you have to prefer the surgical method such as gastric bypass, which remains the only therapeutic treatment and the anti-obesity pharmacotherapy remains very limited therefore the priority is to discover or develop more potent drugs. The only potential strategy is to achieve weight loss it can be done by either reducing energy intake or by stimulating anorexigenic signals or by blocking orexegenic signals and to increase energy expenditure. This can be achieved by stimulating the Oxm, peptide PYY, GLP, GLP-1 receptor, and fat cells derived hormone like Leptin and Obestatin these reduces obesity by reducing food intake as seen in mice and humans by stimulating satiety signals, and by regulating the glucose homeostasis, by secreting glucose dependent insulin.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Oxyntomodulin</kwd>
        <kwd>Obestatin</kwd>
        <kwd>Leptin</kwd>
        <kwd>anti-obesity</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
